|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 84.69 USD | 0.00% |
|
-0.01% | +81.93% |
| Market Cap | 8.98B 7.69B 7.2B 6.59B 12.37B 859B 12.53B 85.06B 33.17B 432B 33.73B 33B 1,428B | P/E 2026 * |
-18.2x | P/E 2027 * | -20.6x |
|---|---|---|---|---|---|
| Enterprise Value | 7.98B 6.83B 6.39B 5.85B 10.98B 763B 11.13B 75.54B 29.46B 383B 29.95B 29.3B 1,268B | EV / Sales 2026 * |
104x | EV / Sales 2027 * | 46.2x |
| Free-Float |
98.09% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Crinetics Pharmaceuticals, Inc.
| 1 week | -0.01% | ||
| Current month | +1.40% | ||
| 1 month | +0.94% | ||
| 3 months | +128.34% | ||
| 6 months | +94.96% | ||
| Current year | +81.93% |
| 1 week | 84.61 |  | 84.8 |
| 1 month | 83.47 | | 84.8 |
| Current year | 32.3 | | 84.8 |
| 1 year | 29.91 | | 84.8 |
| 3 years | 15.76 | | 84.8 |
| 5 years | 15.23 | | 84.8 |
| 10 years | 10.63 | | 84.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
R. Struthers
CEO | Chief Executive Officer | 64 | 2008-11-30 |
Stephen Betz
CTO | Chief Tech/Sci/R&D Officer | 60 | 2021-09-30 |
Tobin Schilke
DFI | Director of Finance/CFO | 51 | 2025-02-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Wendell Wierenga
CHM | Chairman | 78 | 2015-09-30 |
R. Struthers
BRD | Director/Board Member | 64 | 2008-10-31 |
Matthew Fust
BRD | Director/Board Member | 61 | 2018-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/7/26 | Fiscal year | Founder | 39,856 | 0.0378% | ||
| 7/2/26 | Sell | Director | -3,000 | 0.0028% | ||
| 3/12/26 | Sell | Director | 5,000 | 0.0048% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -0.01% | +188.06% | +427.66% | 8.98B | |
| -3.00% | +2.27% | +77.60% | +109.33% | 72.12B | |
| +1.90% | +23.53% | +56.60% | +97.76% | 65.85B | |
| +5.12% | +25.22% | +5.24% | -0.82% | 29.28B | |
| +0.55% | +1.64% | -5.15% | +471.68% | 27.47B | |
| +2.74% | +12.98% | +62.84% | +28.14% | 26.7B | |
| +0.47% | +6.12% | +36.66% | -13.79% | 20.06B | |
| +1.82% | -6.67% | +247.46% | +393.10% | 18.22B | |
| +0.94% | +3.36% | +18.55% | +532.94% | 16.4B | |
| +0.73% | +5.54% | +39.71% | +153.07% | 13.4B | |
| Average | +1.13% | +7.53% | +72.76% | +219.91% | 29.85B | |
| Weighted average by Cap. | +0.72% | +9.20% | +62.93% | +165.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 76.86M 65.84M 61.6M 56.39M 106M 7.35B 107M 728M 284M 3.69B 289M 282M 12.22B | 180M 155M 145M 132M 248M 17.26B 252M 1.71B 666M 8.67B 677M 663M 28.68B |
| Net income | -507M -435M -407M -372M -699M -48.55B -708M -4.81B -1.87B -24.39B -1.91B -1.86B -80.67B | -463M -397M -371M -340M -638M -44.34B -647M -4.39B -1.71B -22.27B -1.74B -1.7B -73.67B |
| Net Debt | -1.01B -861M -806M -738M -1.38B -96.2B -1.4B -9.52B -3.71B -48.32B -3.78B -3.69B -160B | -647M -554M -519M -475M -891M -61.9B -903M -6.13B -2.39B -31.1B -2.43B -2.38B -103B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | US$84.69 | 0.00% | 2,016,688 |
| 26-08-20 | US$84.69 | 0.00% | 9,003,934 |
| 26-08-19 | US$84.69 | -0.04% | 2,141,443 |
| 26-08-18 | US$84.72 | -0.04% | 3,971,944 |
| 26-08-17 | US$84.75 | +0.06% | 1,638,517 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
